Background In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015.
Introduction
The global community adopted a set of 17 Sustainable Development Goals (SDGs) on Sept 25, 2015 , to provide benchmark targets for global development between 2015 and 2030.
1 These goals are intended to build on the momentum and enthusiasm generated by the Millennium Development Goals (MDGs), 2 but also to reframe them within the context of a myriad of environmental and societal challenges inherent in achieving sustainable global development, 3, 4 The Global Strategy for Women's, Children's, and Adolescents ' Health 2016 ' Health -2030 further aims to position the global discussion of maternal mortality within a continuum of programmes aimed at improving the health of women and children globally.
for women in the SDG era. 6 Whereas MDG 5 set a target reduction of 75% in the maternal mortality ratio (MMR; number of maternal deaths per 100 000 livebirths) between 1990 and 2015, SDG 3.1 sets a specifi c target for all countries to lower MMR to less than 70 by 2030. A secondary target of MDG 5, adopted in 2005, called for universal access to reproductive health care with named subtargets for contraceptive prevalence, adolescent pregnancy, antenatal care coverage, and family planning services, 7 but notably not for other reproductive health services such as skilled birth attendance, in-facility delivery, or EmOC services. Because of the late addition of reproductive health access to the MDG agenda, related data collection systems have taken time to mature and this issue has not been tracked as closely as maternal mortality. SDG 3.7 has continued the calls for universal access to sexual and reproductive health services by 2030.
We have completed this study as part of the Global Burden of Disease (GBD) 2015, with the specifi c objective of ascertaining levels and trends in maternal mortality over the entire MDG period at the national, regional, and global levels. Relatedly, by also examining maternal mortality trends by age, cause, geography, and timing of death, we seek to better understand trends in maternal mortality epidemiology and thus generate insight into drivers of progress-or lack thereof-toward achievement of MDG 5 and help to frame discussions for monitoring of SDG 3.1 and 3.7 . Multiple previous analyses, including several completed as part of the GBD collaboration have sought to provide the best possible information about levels and trends in maternal mortality. [8] [9] [10] [11] [12] [13] [14] In dual recognition of both the importance and diffi culty of accurately reporting on maternal mortality in many settings, 15, 16 each has incorporated increasingly large and geographically precise datasets and used more advanced statistical models. In their latest iteration, 12 the WHO methods have also now adopted a single model for all countries and computed statistical uncertainty intervals. Important diff erences remain, however, between WHO and GBD maternal mortality estimates that at times paint divergent pictures of levels and trends in maternal mortality globally and in many countries. The main diff erences now stem from data selection, quality appraisal, data processing, and adult mortality estimation rather than the statistical maternal mortality models themselves.
In this GBD 2015 report, we present the underlying data for 519 distinct geographical units in 195 countries and territories, our methods for processing those data, the subsequent analytical approach, and fi ndings on maternal mortality from 1990 to 2015. GBD 2010, published in 2012, presented results for 187 countries with a population greater than 50 000 in the year 2000. 17 Collaborative teams completed subnational assessments for the UK, Mexico, and China for GBD 2013, expanding the number of geographies in the GBD analysis to 296. [18] [19] [20] [21] The value of subnational assessments to local decision makers 22 has led to expansion of subnational analyses in GBD 2015 to also include Brazil, India, Japan, Kenya, Saudi Arabia, South Africa, Sweden, and the USA. We expect subnational analyses for other countries will be added in future GBD iterations. The expansion of the geographical units in the GBD will continue in a way that will sustain comparability over time for the period 1990 to present and across all geographical entities. We have not included constant rate-of-change forecasts in this Article because, as part of the broader eff ort to quantify the population disease burden, we are developing a set of rigorous statistical models to forecast each component of the GBD-including maternal mortality-and we expect to be able to explore much more robust forecasts in the near future.
As with all GBD revisions, the GBD 2015 study describes updated maternal mortality estimates for the entire time series from 1990 to 2015 based on newly identifi ed data sources released or collected since GBD 2013. In response to published commentaries and un published seminars and communications on GBD methods, various methodological refi nements have been implemented. 23, 24 In addition, a major eff ort toward data and code transparency has been part of the GBD 2015 cycle. And as with each GBD cycle, the full time series published here supersedes previous GBD studies. This analysis explores global, regional, national, and sub national progress and seeks to identify correlates that help to explain why some nations have seen great improve ments in maternal health, while others have stagnated and others still have worsened. These include examination of associations in national maternal mortality levels and trends with coverage of reproductive health interventions and Socio-demographic Index (SDI).
Methods

Overview
Maternal mortality is defi ned as a death that occurs to a woman as a direct result of obstetric complications or indirectly as a result of pregnancy-induced exacerbation of pre-existing medical conditions, but not as a result of incidental or accidental causes. To ensure internal consistency with all other causes of death, maternal mortality was also again analysed as a component of the overall GBD study. Many of the analytical components are therefore shared with other causes, including methods of data source identifi cation and cataloguing, data preparation, modelling platforms, and processing of results. Here, we will focus on parts of the process that are unique, have been updated since GBD 2013, or are especially relevant to our analysis of maternal mortality. Figure 1 illustrates details of the analysis. General components are described in the appendix (pp , in other GBD 2015 Articles in The Lancet, and have also been published previously. 10, 20, 25 This report follows the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) guidelines, which recom mends documen tation of data sources, methods, and analysis. 26 
Maternal mortality estimation Geographical units of analysis
Our analysis was completed separately for 519 unique locations in 195 countries and territories, including all 188 countries analysed in GBD 2013 as well as seven additional countries or territories-namely, American Samoa, Bermuda, Greenland, Guam, Northern Mariana Islands, Puerto Rico, and the Virgin Islands, where highquality vital registration data were available. Of note, these territories were not included in the national totals for Denmark, the UK, or the USA, but were instead included in GBD 2013 regional totals. All 195 countries are hierarchically organised into 21 regions, each of which is nested in one of seven super regions. Based on a combination of data availability and collaborator interest, we disaggregated GBD 2015 analyses into subnational units for several countries, including 26 states and one district for Brazil, 34 provinces and municipalities for China, 31 states and union territory groupings for India that include 62 rural and urban units, 47 prefectures for Japan, 47 counties for Kenya, 32 states and districts for Mexico, 13 provinces for Saudi Arabia, nine provinces for South Africa, two regions for Sweden, 13 regions for the UK (Northern Ireland, Scotland, Wales, England, and nine subregions of England), and 51 states and districts for the USA. At the fi rst subnational unit level, we have a total of 256 geo graphical units. In this Article, we present results for countries and territories, regions, super regions, SDI quintiles, and at the global level.
Data input and processing
The contents of the dataset used in our fi nal model are shown in the appendix (p 667) and are compared with those used by the recent WHO analysis. 12 A map showing the data coverage by location for all source types combined is shown in the appendix (p 57). We had 599 unique sources from data from 186 of 195 countries (95%), covering 12 052 site years, an increase of 71% from GBD 2013 when we had 7056 total site years of maternal mortality data. This compares to only 203 sources covering 2636 total site years in the WHO analysis. The nine countries without maternal mortality data included Andorra, Angola, Equatorial Guinea, the Federated States of Micronesia, Marshall Islands, Samoa, Solomon Islands, Somalia, and Vanuatu. Maternal mortality data See Online for appendix were also available for additional subnational locations in Mexico, China, the UK, Japan, the USA, Kenya, South Africa, India, Sweden, and Brazil. All data were stored in a centralised structured query language causes-of-death database in three formats: number of deaths, causespecifi c mortality rate per capita, and cause fraction (proportion of all deaths due to maternal causes).
Vital registration systems have been shown to underestimate maternal mortality, but the amount of underestimation varies by setting and can change over time. [22] [23] [24] We therefore used a method that maximises the data-driven nature-and specifi city-of our adjustments by systematically evaluating each underlying data source. We included all sources with population-level data for maternal mortality from each geography. We used a standardised process to identify, extract, and process all relevant data sources, including those from vital registration systems, verbal autopsy studies, maternal surveillance systems, national confi dential enquiry reports, and sibling survival histories from health surveys and censuses (fi gure 1, step 1).
Standardised algorithms were implemented to adjust for age-specifi c, year-specifi c, and geography-specifi c patterns of incompleteness and underreporting for vital registration, as well as patterns of misclassifi cation of deaths in vital registration and verbal autopsy sources (fi gure 1, step 2). These generalised algorithms were used across all GBD causes and thus were able to capture Ovals represent data inputs, square boxes represent analytical steps, cylinders represent databases, and parallelograms represent intermediate and fi nal results. Numbers are steps of the prcoess. The fl owchart is colour-coded by major estimation component: data preparation and overall maternal mortality in blue; cause-specifi c and timing-specifi c estimation in green; analysis and data specifi c to the role of HIV/AIDS in maternal mortality in pink; steps related to demographic and computational processes that ensure internal consistency in orange, and fi nal estimates in dark blue. trends in quality changes in vital registration with respect to maternal mortality, even in locations where surveillance studies have not been completed. 20 Each code in International Classifi cation of Diseases (ICD)-coded vital registration datasets was uniquely assigned to a corresponding cause in the hierarchical GBD cause list. Codes used in tabular classifi cation systems (eg, ICD-9 basic tabular list, verbal autopsy, maternal surveillance systems) were likewise uniquely matched with a GBD cause. A proportion of deaths assigned to causes that cannot be underlying causes of death (garbage coded) were reassigned to maternal causes based on statistical redistribution packages, as described in the appendix (pp 2-18). The net eff ect of data processing steps on vital registration across all locations and years combined was to increase maternal deaths by 168%. The net eff ect varied by geography and year even among those countries and territories with at least 10 years of data, ranging from less than 1% increase in Mongolia to a nine-fold increase in China. Final and raw vital registration data for each The list of causes on the left are raw ICD-10 cause codes according to death certifi cation data sources and those on the right are the fi nal target aetiologies for maternal mortality. The height of each bar is proportional to the number of deaths in each category. The colours are for ease of visualisation. Redistribution categories: A41=other sepsis; A419=sepsis, unspecifi ed organism; D649=anaemia, unspecifi ed; D65=disseminated intravascular coagulation; G809=cerebral palsy, unspecifi ed; G931=anoxic brain damage, not elsewhere classifi ed; I26=pulmonary embolism; I269=pulmonary embolism without acute cor pulmonale; I743=embolism and thrombosis of arteries of the lower extremities; I749=embolism and thrombosis of unspecifi ed artery; K650=generalised (acute) peritonitis; K659=peritonitis, unspecifi ed; N179=acute kidney failure, unspecifi ed; N19=unspecifi ed kidney failure; O95=obstetric death of unspecifi ed cause; R98=unattended death; R99=ill-defi ned and unknown cause of mortality; ZZZ=causes violating age/sex limitations); reg_gc_left_hf_anaemia=anaemia due to left heart failure; other garbage=all other garbage codes. ICD-10=International Classifi cation of Diseases 10. GBD=Global Burden of Disease.
country and year are shown in the appendix (pp 519-652), including proportion of all deaths assigned to garbage codes, and comparisons with WHO vital registration adjustments.
12 Figure 2 shows the results of garbage code redistribution for maternal mortality at the global level. Distinct cause groupings, many of which are garbage codes, are shown on the left and the relative thickness of lines shows the proportion of all deaths from those codes that were subsequently mapped to corresponding maternal causes on the right. Note that by defi nition the so-called non-garbage codes on the left map directly to maternal causes.
In view of their inconsistent use by vital registration systems, codes pertaining to HIV-related indirect maternal deaths were excluded at this stage in favour of a more comprehensive approach to estimate the eff ect of HIV on maternal death (see below for more details of HIV-related maternal mortality analysis). In addition to vital registration, we identifi ed maternal mortality surveillance systems and published confi dential enquiry studies identifi ed via targeted web search and systematic review of national ministry of health websites. Confi dential enquiries are specialised studies designed to investigate the number and circumstances of maternal deaths. Inclusion required a clear distinction identifi ed between maternal and incidental deaths during pregnancy. As with vital registration systems, HIVrelated indirect maternal deaths were excluded from surveillance datasets at this stage (see below for more details) but otherwise were unadjusted. Single-year sibling history and survey data derived from health surveys and censuses was processed as in GBD 2013, using Gakidou-King weights to adjust for survivor bias and only retaining data from older surveys when years of death overlapped (fi gure 1, step 3). 27 Our general approach to quantify the role of HIV in maternal mortality is unchanged from GBD 2013 and again involved comprehensive estimation of the population attributable fraction of maternal mortality to HIV 10 (fi gure 1, step 4). In view of the increased baseline mortality of those with advanced HIV, this approach has helped to distinguish between deaths in HIV-positive women that were caused by pregnancy and those for which the pregnancy was incidental to their death. A detailed description of the GBD 2013 approach and updates is in the appendix (pp [21] [22] [23] [24] . An updated systematic literature search completed on July 20, 2015, did not identify any new sources to inform either our meta-analysis of relative risk of pregnancy-related death for HIV-positive versus HIV-negative women or our analysis on the proportion of pregnancy-related deaths in HIV-positive women that are maternal (versus incidental). HIV prevalence in pregnancy, approximated as the ratio of livebirths in HIV-positive to HIV-negative women, was updated using our modifi ed EPP-Spectrum model. We also made two important improvements to overall HIV mortality estimation, both of which aff ected our HIV-related maternal mortality estimates. First, to improve the internal consistency of estimates developed for countries with generalised HIV epidemics, we modifi ed EPP-Spectrum to improve how it integrates ARTdependent HIV progression and mortality data from published cohort studies and combined these fi ndings with results derived from statistical examination of how all-cause mortality relates to crude HIV death rate. Second, in recognition of the fact that HIV mortality rivals or exceeds that of high mortality events (referred to as socalled fatal discontinuities in GBD 2015) such as war and natural disaster in many locations-and that such discontinuities have major detrimental eff ects on statistical mortality models-all of our maternal mortality data were processed to ensure incidental HIV deaths were excluded before modelling. We processed sibling history and census data to exclude incidental HIV deaths using population attributable fractions calculated above for each geography, age group, and year. This method is analogous to the HIVcorrection process used in GBD 2013 except that the correction was done on the data itself rather than the preliminary model results. To ensure consistency between all data sources, we also applied population attributable fractions to all vital registration, verbal autopsy, and surveillance data to add back the corresponding number of HIV-related indirect maternal deaths in each of those sources. Finally, to reduce error introduced by large stochastic fl uctuations and upward bias introduced by data that have a value of zero, we processed all data of all specifi cations using Bayesian noise-reduction algorithms (see appendix [pp [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] for more details; fi gure 1, step 5). Zeros are problematic because the log of zero is undefi ned, so all zeroes would otherwise be ignored by log-based statistical mortality models.
Modelling overall maternal mortality
We again modelled overall maternal mortality using cause-of-death ensemble modelling (CODEm), which was developed for GBD 2010 28 and is described in detail in the appendix (fi gure 1, step 6). CODEm runs four separate models, including natural log of age-specifi c death rates and logit-transformed cause-fractions in each of linear and spatiotemporal Gaussian process regression formats. Using multiple holdout patterns and cross-validation testing, every combination of covariates was tested. Models where regression coeffi cients met requirements for direction and signifi cance were then ranked on the basis of out-ofsample predictive validity performance through multiple iterations of cross-validation testing. We then generated a series of ensemble models with a range of weightings such that top-performing component models contributed the most to the fi nal prediction. We ran two separate CODEm models, one for countries with extensive complete vital registration representation and another for all countries combined (see appendix pp 655-59 for a list of countries and territories with extensive complete vital registration included in separate CODEm model). The purpose was so that heterogeneous data from countries without extensive complete vital registration representation would not infl ate the uncertainty interval (UI) for countries with extensive and complete cause-specifi c death data. Results from the former model were used for all geographies with extensive complete vital registration representation; results for all other geographies were from the latter model.
Predictive covariates were specifi ed with respect to required directionality and signifi cance level of regression coeffi cients (see appendix [p 661] for full details). Three hierarchical covariate levels reduce the combinatorial burden on CODEm. Covariates with strong or causal association were assigned to level 1; those that are ecologically related were assigned to level 2; and those where association is suspected but not proven at the population level were assigned to level 3. We largely used the same covariates as in GBD 2013, including age-standardised fertility rate, total fertility rate, years of education per capita, lag-distributed income (international $ per capita), neonatal mortality rate (per 1000 livebirths), HIV mortality in females of reproductive age, and the coverage proportion of one visit of antenatal care, four visits of antenatal care, skilled birth attendance, and in-facility delivery. Several new covariates were introduced in this analysis in recognition of their potential relation to maternal mortality, all of which were specifi ed as level 3. Obesity prevalence was added to help to refl ect the added complexity of care and heightened risk of maternal complications in those who are obese. 29, 30 Mortality death rate from fatal discontinuities, a covariate that aggregates the eff ects of war, famine, and natural disaster, was introduced to help to inform maternal mortality estimates in geographies where demographic shocks have led to interruption of vital statistics and where health systems are also hypothesised to have deteriorated. 31, 32 Hospital beds per 1000 population was added based on the hypothesis that it might be a proxy for the availability of basic EmOC. 33 SDI, based on principal component analysis of fertility, maternal education (years per capita), and lag-distributed income (international $ per capita), was added as a covariate to all CODEm models in GBD 2015. The root-mean SE of the top-performing ensemble model was 0·318 for the CODEm model of countries with extensive complete vital registration model and 0·553 for the global model. In-sample and out-of-sample data coverage was 99·6% and 99·3%, respectively, for the CODEm model of countries with extensive complete vital registration, and 98·3% and 97·7%, respectively, for the global model. The relative contributions of each of the covariates and submodel performance for all component models in the top-performing CODEm ensemble are shown in the appendix (pp 662-75).
Modelling underlying cause and timing of maternal mortality
Our approach to quantify underlying cause and timing of maternal deaths was largely unchanged from GBD 2013, although in some cases we changed cause names to better refl ect the ICD-9 and ICD-10 codes contained therein. ICD-9 and ICD-10 codes corresponding to each category are in the appendix (p 653). We examined six groups of direct obstetric causes, including maternal hypertensive disorders; maternal haemorrhage; maternal abortion, miscarriage, and ectopic pregnancy; maternal obstructed labour and uterine rupture; maternal sepsis and other maternal infections; and other maternal disorders. Two categories of indirect obstetric causes included maternal deaths aggravated by HIV/AIDS and indirect maternal disorders. Late maternal deaths occurring between 42 days and 1 year after the end of pregnancy were estimated as a separate cause (ICD-10 code, O96). Two diff erences can be noted between the GBD and ICD-maternal mortality modifi cation classifi cation systems, neither of which are new in this study, but nonetheless warrant mention in that they each refl ect important clinical aspects of pregnancy complications. First, the GBD has grouped uterine rupture with obstructed labour rather than maternal haemorrhage, in recognition that most uterine rupture cases are secondary to inadequately addressed or prolonged obstruction of labour. Second is the combining of abortion, ectopic pregnancy, and miscarriage into one cause. Although there are important diff erences between them, we treated them similarly with the rationale that safe interventions can be similar during early pregnancy (eg, medication, potentially dilation, and evacuation), as can management of life-threating complications such as infection and bleeding, which require prompt evaluation, diagnosis, and often emergency surgical intervention. We also examined four distinct time windows of maternal death. In addition to late maternal deaths, we estimated deaths occurring during the antepartum period (before onset of labour), intrapartum and immediate post partum (onset of labour up to <24 h after delivery), and early and delayed post partum (24 h to 42 days after delivery). We analysed late maternal death as both a timing category and as a distinct cause because the underlying causes of late maternal deaths are not specifi ed in most data sources.
Systematic literature reviews identifi ed studies that examined underlying causes and timing of maternal deaths (fi gure 1, step 7). We extracted additional information from specialised studies such as confi dential enquiries and maternal mortality review boards that were obtained from targeted web searches or from correspondence with GBD collaborators. We supplemented aetiology models with cause-specifi c data from the causesof-death database. Of note, our criteria for including data from the causes-of-death database was modifi ed from GBD 2013 to include all data from any source where specifi c subcauses were coded rather than limiting to only those sources where the complete complement of subcauses were included. This change had the eff ect of substantially increasing the size of our analytical dataset with respect to time and geography. Late maternal death data from the causes-of-death database were limited to those location years where at least 0·5% of all maternal deaths in raw vital registration data fi les were coded to late maternal deaths as this was the lowest proportion reported in any surveillance studies. 34 Only 39 countries met these criteria with variable times in which they began coding late maternal deaths. Timing models were additionally supplemented with temporal information about pregnancy-related deaths from Demographic and Health Surveys maternal mortality modules. These data only reported on antepartum, intrapartum, and post-partum death. To maximise the volume and geographical distribution of data to inform causal attribution, we again modelled the proportion of deaths due to each cause and timing category using DisMod-MR 2.1.
The exception was HIV-related maternal mortality, for which the proportion was estimated using the population attributable fraction approach described above (fi gure 1, step 9). All data for cause and timing models for which late maternal death was excluded were statistically crosswalked within DisMod-MR 2.1 to the reference defi nition where late maternal death is included. Analytical details of DisMod-MR have been previously described. 10 Further description, including details about updates contained in DisMod-MR 2.1 and statistical crosswalks, are also included in the appendix (pp [21] [22] [23] [24] . To correct for ascertainment bias inherent in the introduction of late maternal death partway through the MDG period, we corrected overall maternal mortality estimates for the systematic exclusion of late maternal death in those location years where it was not coded (fi gure 1, step 10). Selection criteria to identify those geographies and years to be corrected are described above. Geographies where coding of late maternal deaths was introduced partway through the time period were only corrected for the years before introduction. Agespecifi c, year-specifi c, and geography-specifi c proportions predicted by DisMod-MR 2.1 for underlying causes and timing were then applied to the overall maternal mortality model developed in CODEm (fi gure 1, step 11).
Ensuring consistency with all other causes of death
Another crucial strength of the GBD approach to maternal mortality is that all results are internally consistent with all other specifi c causes of death (fi gure 1, step 12). CoDCorrect is a process that uses a simple algorithm to scale all cause-specifi c deaths from all causes for each age group, sex, year, and location, and thereby ensures that the sum equals total all-cause mortality. For maternal mortality, it further scaled the sum of all cause-specifi c and timing-specifi c estimates to equal the total for all maternal mortality. Further details on CoDCorrect and its implementation are described in the appendix (p 48).
Age groups and fertility
Previous analyses have truncated evaluation of maternal mortality at 15 years to 49 years. Doing so ignores the non-trivial number of pregnancies and deaths occurring in those younger than 15 years and older than 50 years.
35
Deaths in these age groups are routinely coded in our data sources, so for the fi rst time, we have expanded the age range of our maternal mortality analysis to include all 5-year age groups from 10 years to 54 years in GBD 2015.
To facilitate calculation of MMR in these age groups, our demographic analysis included expansion of UN Population Division estimates of age-specifi c livebirths to include 10-14 years and 50-54 years (fi gure 1, step 13). The appendix (pp [49] [50] [684] [685] [686] [687] [688] [689] [690] [691] [692] [693] [694] [695] [696] [697] [698] [699] [700] [701] provides more detail on fertility estimation in these age groups and a table of agespecifi c livebirths for all locations.
Uncertainty analysis
We report 95% UIs for all estimates. UIs include uncertainty introduced by variable sample sizes, data adjustments for all-cause mortality sources, and cause-specifi c model specifi cations and estimation. In CODEm, after a model weighting scheme has been chosen, each model contributes a number of draws proportional to its weight such that 1000 draws are created. The mean of the draws is used as the fi nal estimate for the CODEm process and 95% UI are created from the 0·025 and 0·975 quantiles of the draws. In DisMod-MR 2.1, uncertainty is calculated by sampling 1000 draws from the posterior distribution of each mostdetailed geography, age group, and year. UIs for underlying causes and timing are propagated from the combination of CODEm and DisMod-MR 2.1 draws. We propagated uncertainty into all the fi nal quantities of interest at all levels of geographic, temporal, and age-specifi c aggregations assuming no correlation between them.
Analysis of levels and trends MMR, annualised rate of change, and reporting metrics
We report number of deaths and MMR; number of deaths per 100 000 livebirths) for ages 10-54 years inclusive. We calculated MMR for each 5-year age group separately using age-specifi c livebirths (fi gure 1, step 14). We calculated annualised rate of change (ARC) using the two-point continuously compounded rate-of-change formula 36 in each geography separately for 1990-2000, 2000-15, 1990-2015 , and all single years throughout the time period. ARC examination shows overall trends, highlights periods of acceleration (or deceleration) in improvement, and allows identifi cation of those countries that probably achieved MDG 5.
Drivers of change in the MDG era, coverage target setting for SDGs
For GBD 2015, we completed two additional analyses to systematically describe drivers of levels and trends in maternal mortality. First, we examined the relation between MMR and SDI, a summary indicator derived from measures of income per capita, educational attainment, and fertility using the Human Development Index method. 37 The SDI has an interpretable scale: zero represents the lowest income per capita, lowest educational attainment, and highest total fertility rate noted across all GBD geographies from 1980 to 2015 and one represents the highest income per capita, highest educational attainment, and lowest total fertility rate. We then used spline regression to calculate the average relation between MMR and SDI, thereby facilitating further evaluation of geographical and temporal MMR trends. Further details of SDI development and spline regressions are in the appendix (p 48). We then used the average relation between SDI and MMR to calculate observed minus expected (O-E) MMR ratio and O-E ARC (from 2000 to 2015), respectively, to show average patterns that can help to benchmark a country against other countries and provides insights into whether or not public action or other factors have been leading to narrowingor growing-inequalities since the MDG declaration. Second, to capture how improvements in women's access to the specifi c modes of reproductive health care might change the average relation observed between SDI and MMR, we also examined the relation between MMR and coverage of one visit of antenatal care, four antenatal care visits (a proxy for more comprehensive care), in-facility delivery, and skilled birth attendance by calculating the average coverage of each over diff erent MMR ranges.
Role of the funding source
The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The authors had access to the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Global and country-specifi c maternal mortality
Global maternal deaths decreased slightly from 390 185 (95% UI 365 193-416 235) in 1990 to 374 321 (351 336-400 419) in 2000 before dropping to 275 288 (243 757-315 490) in 2015 (fi gure 3). The overall decrease from 1990 to 2015 in global maternal deaths was roughly 29% and the decrease in MMR was 30%. Table 1 shows results for all specifi c geographies in the GBD hierarchy. MMR followed a similar trend to overall maternal deaths; MMR was 282 (95% UI 264-300) in 1990, 288 (270-308) in 2000, and decreased to 196 (173-224) in 2015. Global ARC was -1·5% (95% UI -2·0 to -0·9) across the entire MDG period from 1990 to 2015. Global ARC was initially relatively fl at at 0·2% (-0·5 to 0·9) from 1990 to 2000, but accelerated greatly after the Millennium Declaration to be -2·6% (-3·4 to -1·7) from 2000 to 2015. Looking at single-year ARC, we see the global acceleration began in the year 2001 and has continued accelerating until 2007-08, after which the rate of improvement has slowed. 1 9 9 0 -9 1 1 9 9 2 -9 3 1 9 9 4 -9 5 1 9 9 6 -9 7 1 9 9 8 -9 9 2 0 0 1 -0 2 2 0 0 3 -0 4 Year 2 0 0 5 -0 6 2 0 0 7 -0 8 2 0 0 9 -1 0 2 0 1 1 -1 2 2 0 1 3 -1 4 2 0 1 4 -1 5 1 9 9 1 -9 2 1 9 9 3 -9 4 1 9 9 5 -9 6 1 9 9 7 - 9 
Israel 11 (10 to 13) 10 (9 to 11) 10 (8 to 11) Geographical diff erences in maternal mortality are readily apparent. In 1990, 60 countries had an MMR greater than 200, 40 countries had an MMR of greater than 400, and 15 greater than 600 (appendix pp [58] [59] [60] [61] [62] . Only one country-Burundi-had an MMR greater than 1000. MMR was less than 70 in 93 countries at that time. A subset of 50 countries had an MMR of less than 30, and 28 countries were less than 15. By the year 2015, as shown in fi gure 4, 122 countries had an MMR of less than 70, and 49 countries had an MMR of less than 15, including Saudi Arabia, all countries in central Europe, and all high-income locations with the exception of the USA, Argentina, Brunei, Chile, and Uruguay. Several other countries in North Africa and Middle East along with the USA, Armenia, Azerbaijan, Bulgaria, Chile, China, Costa Rica, Kazakhstan, Puerto Rico, Romania, Russia, Tajikistan, Thailand, Turkmenistan, Ukraine, Uruguay, Uzbekistan, and Vietnam had an MMR between 15 and 30. Unfortunately, there were still 24 countries with an MMR of greater than 400, eight countries with greater than 600, and still one-Central African Republic-greater than 1000. Of those greater than 600, Sierra Leone, Afghanistan, and Central African Republic actually worsened, with ARC from 1990 to 2015 of 2·7% (-1·3 to 6·3), 0·34% (-2·1 to 2·7), and 0·08% (-5·5 to 4·9), respectively. Of those countries with an MMR higher than 400 in 1990, Burundi and Equatorial Guinea improved substantially by 2015 with total improvements of -4·3% (-8·7 to 0·3) and -4·2% (-9·6 to 3·9), respectively.
MDG 5 achievement
To achieve the primary objective of MDG 5, the ARC must have met or exceeded an average of -5·5% during the entire time period from 1990 to 2015. Based on this metric, a total of ten countries probably achieved MDG 5, including Iceland, Jordan, Maldives, Belarus, Morocco, Romania, China, Turkey, Poland, and Estonia. Several 
Relation between MMR, SDI, and reproductive health services
As shown in table 2, maternal mortality in the lowest SDI quintile improved the least, with ARC of only -0·97% (-1·8 to -0·001) from 1990 to 2015, and the low-middle SDI quintile was the next slowest with an ARC of -2·1% (-2·8 to -1·1). The proportion of all maternal deaths occurring in the bottom two SDI quintiles increased from roughly 68% in 1990 to more than 80% in 2015. The middle SDI quintile improved the fastest with ARC of -3·2% (-3·8 to -2·6) over the entire time period. Table 1 : Global, regional, and national or territory number of maternal deaths, maternal mortality ratio (MMR; number of deaths per 100 000 livebirths), and annualised rates of change in percent, 1990-2015 international $9442 per capita, 8·2 years of education, and total fertility rate of 2·5. Not all countries might be able to achieve that level of income, however, but education and fertility reduction eff orts could still be compatible with reaching this SDI level. If all women were to complete a full 12 years of education and total fertility rate of 2·7, an SDI of 0·65 would on average be associated with income of $3214 per capita. If total fertility rate were to decrease further to the population replacement rate of to 2·0 and education were 12 years, this SDI level would only require an annual income of $2648 per capita. MMR and SDI both improved between 1990 and 2015 in almost all regions, but MMR did not universally track with SDI over the entire time period in any single region. East Asia has had the lowest O-E MMR ratio since 2011, a period in which it has consistently been less than 0·4 of expected. Australasia has also had consistently lower MMR than would be predicted on the basis of SDI, with O-E MMR ratio ranging from 0·54 in 1990 to 0·71 in 2015. In addition to east Asia and Australasia, several other regions have consistently had lower MMR than would have been expected by SDI, including central Asia, central Europe, eastern sub-Saharan Africa, Western Europe, and high-income Asia Pacifi c. Southern Latin America and north Africa and the Middle East both had lower than expected MMR in 1990 when both had O-E MMR ratios of less than 0·7, but improvement has not kept pace with SDI gains in either region: by 2015, O-E MMR ratios were 2·23 and 1·41, respectively. Central sub-Saharan Africa has been an exception in several ways. In addition to having the highest MMR of any region in 2015, MMR worsened from 1990 to 2015. Despite maternal mortality being high in central sub-Saharan Africa, it was still lower than would have been expected until 2014 because SDI is still so low in that region and has improved only slowly.
O-E MMR ratio has consistently been 1·25 or more in a larger number of regions, including the Caribbean, eastern Europe, high-income North America, Oceania, south Asia, southeast Asia, and southern sub-Saharan Africa. Andean Latin America had periods of rapid improvement in MMR during the early 2000s that exceeded that expected based on SDI. Unfortunately, MMR reductions there have slowed substantially since then, to the point where O-E MMR ratio was 1·41 in 2015. Improvements in eastern Europe have been faster than SDI after the year 2000, but MMR improvement in the remaining regions has continued to be slower than expected on the basis of SDI. Southern sub-Saharan Africa and the Caribbean had the highest O-E MMR ratios of any regions at 3·57 and 3·71, respectively, in 200-250 250-300 300-400 400-500 500-600 600-1100
Persian Gulf 2015, but both have had recent periods of MMR improvement that were much more rapid than expected on the basis of SDI. These trend reversals began in 2006 and 2007, respectively. South Asia and southeast Asia are unique in that although both have made major gains in terms of SDI and MMR, the diff erence between observed and expected MMR based on SDI remained the same. Even within regions, the degree to which MMR diverged on the basis of SDI varied. For each country, we calculated observed ARC minus expected ARC (O-E ARC) on the basis of SDI change from 2000 to 2015 (fi gure 6). In 60 countries, the O-E ARC was faster than would have been expected based on SDI alone, and 25 of these had ARC at least 1·5% faster than expected. Within south Asia, Bangladesh has improved faster than expected, whereas Nepal, Bhutan, and India all had slower MMR reductions. Of the countries in southeast Asia, Cambodia and Laos have improved much faster than expected, whereas Thailand, Philippines, and Malaysia have not. In subSaharan Africa, Namibia, Malawi, and Burundi were all more than 1·5% faster than expected, but ARC in most of the countries of eastern and western sub-Saharan Africa exceeded SDI-based expectations. By contrast, only Gabon in central sub-Saharan Africa The coverage values for each aspect of reproductive care show the simple average of all observation for all location-years within the corresponding MMR range. reduced MMR as rapidly as expected, with the Democratic Republic of the Congo and Equatorial Guinea both more than 3% slower. 93 countries had an O-E ARC of 1·5% or more, and there were 17 countries where O-E ARC was greater than 5%.
To begin exploring the hypothesis that MMR improvements are related to coverage of specifi c modes of reproductive health care, we examined the relation between MMR and coverage of one visit of antenatal care, four antenatal care visits, in-facility delivery, and skilled birth attendance over the period from 1990 to 2015 (table 2) . We found that, on average, countries with an MMR of less than 15 had 98% coverage of one antenatal care visit, 95% of four antenatal care visits, 97% of in-facility delivery, and 99% of skilled birth attendance. Those with an MMR of 70-the SDG 3.1 target for all countries-have roughly 91% coverage of one antenatal care visit, 78% of four antenatal care visits, 81% of infacility delivery, and 87% of skilled birth attendance. This is by contrast with those countries with an MMR around 200 where there is an average of 84% coverage of one antenatal care visit, 61% of four antenatal care visits, 63% of in-facility delivery, and 70% of skilled birth attendance, and those locations with an MMR higher than 500 where coverage of all services was low, including just 76% coverage of one antenatal care visit, 45% of four antenatal care visits, 41% of in-facility delivery, and 48% of skilled birth attendance. Comparable datasets were not available to examine the relation between MMR and coverage of either EmOC, distance to obstetric care, post natal care coverage, or family planning services such as modern contraception and access to safe abortion services.
Age pattern of maternal mortality and fertility
The risk of maternal mortality increases greatly with age but decreased greatly in almost all age groups from 1990 to 2015 (appendix pp . Globally in 2015, MMR in 10-14 year olds girls was 278 (95% UI 229-339). MMR then decreased and was lowest in women from 15-29 years old before increasing substantially to 1832 (95% UI 1284-2746) in 50-54 year olds (not shown on graph). Although the largest number of births still occur among women between the ages of 20 years and 29 years (55% of total), adolescent fertility has decreased in and a net shift in births to older women has been noted (appendix pp 684-701). In 1990, 23·3 million (17% of total) livebirths occurred in those women aged younger than 20 years, and 0·58 million (0·42% of the total) were to girls aged 10-14 years. In 2015, 19·4 million (14% of total) births were in those aged 10-19 years, but there were still 0·48 million (0·34% of total) to girls younger than 15 years. By contrast, the absolute number of annual births to women aged 35 years and older increased from 16·1 million (12% of total) in 1990 to 18 million (13% of total) in 2015. ARC in MMR among 10-19 year olds from 2000 to 2015 was -2·3 (95% UI -3·3 to -1·2), which was slower than the global ARC in MMR for all ages combined.
Cause pattern of maternal mortality
Although the risk of death from all causes increases with age, most deaths still occur in younger women and the absolute numbers of deaths from all causes except HIV are higher in younger age groups (see appendix pp 296-98 for number of deaths in 1990, 2000, and 2015 HIV-related maternal deaths were responsible for a portion of the increase in indirect maternal deaths, rising from 754 (95% UI 433-1095) globally in 1990, peaking in the year 2000, and coming down to 2322 (1394-3337) in 2015; this was 0·84% of overall maternal mortality in 2015. 2181 (95% UI 1306-3174) of HIV-related maternal deaths were in sub-Saharan Africa in 2015, roughly 1·6% of the total there. Overall, the contribution of HIV to overall maternal death was quite small, but a large number of women with HIV/AIDS are dying incidentally while pregnant or after delivering. If we include incidental HIV deaths during pregnancy from our population attributable fraction analysis, 20 180 (95% UI 12 120-29 005) HIV-positive women died while pregnant or post partum in 2015 (appendix pp 720-37 shows causespecifi c maternal deaths for all GBD locations).
Changing cause pattern by age
The age pattern for underlying maternal mortality causes in 2015 (fi gure 7) shows that in the youngest age groups, maternal haemorrhage and maternal hypertensive disorders are the dominant causes, together accounting for more than 50% of all maternal deaths. Although the comparative risk associated with maternal hypertensive disorders decreases with age, haemorrhage actually peaked in importance in the 35-39 year olds. The stacked area graph shows the proportion of total maternal deaths due to each cause globally in 2015 as a function of female age group.
The antepartum and post-partum periods were the periods with the largest numbers of deaths in 2015 at 101 774 (95% UI 88 185-117 570) and 85 686 (72 956-101 862) , respectively. The age pattern showed that the proportion of post-partum deaths peaked in the youngest age groups, whereas intrapartum and antepartum deaths were more important in those older than 35 years (appendix pp 299-302). If we look at the change in underlying causal patterns as predicted by SDI (fi gure 8), we see that in the lowest SDI geographies, maternal mortality is dominated by maternal haemorrhage. In high-SDI geographies, by contrast, the causal pattern changes substantially to one where other direct maternal disorders, indirect maternal disorders and abortion, ectopic pregnancy, and miscarriage are the most important causes of maternal death. In middle-SDI geographies, the epidemiological profi le is even more complicated, with a particularly high proportion of maternal deaths being due to maternal hypertensive disorders.
Discussion
In summary, the overall change from 1990 to 2015 in global maternal deaths was roughly -29% and in MMR was -30%, both of which were well short of the MDG 5 goal of -75%. Impediments to MMR reduction are multifaceted and variable; many are also well-conceptualised through the lens of our SDI analysis. First, slow improvement in the two lowest SDI quintiles is one of the primary reasons that maternal mortality reduction has been slower than expected at the global level. In 1990, these two quintiles collectively accounted for 68% of maternal mortality, but by 2015, increased to more than 80% of the global total. Part of the reason is that high adolescent fertility rates in these locations, coupled with comparatively slow improvement in adolescent MMR, led to concentration of maternal mortality burden in young women and girls and higher total fertility in these populations. Second, some middle SDI locations might be experiencing a period of inertia where progress is stalling because health systems have not evolved to meet the challenge of identifying and managing high-risk pregnancies and effi ciently responding to rapid clinical deterioration. Middle SDI geographies have historically had a higher proportion of cases due to conditions such as hypertensive disorders of pregnancy and other direct maternal disorders (eg, cardiomyopathy and embolism). Maternal haemorrhage also evolves with increasing SDI because, as increased in-facility delivery and skilled birth attendance lead to near universal active management of the third stage of labour, an increasing proportion of remaining haemorrhage cases-especially those that result in death-will be due to intractable uterine atony or placental disorders, both of which require high levels of performance and responsiveness from horizontally integrated health systems. 38 This treatise is supported by the observation that many of the countries or regions that improved more rapidly than would have been expected after 2000 were also the biggest recipients of Development Assistance for Health, 39 funds that are often directed toward strengthening health systems, while many of those that have improved more slowly than expected have suff ered from epidemics, natural disasters, and armed confl icts that impair the function of health systems and the willingness or ability of women to seek care. Third, within any given region, heterogeneous or slower-than-expected MMR improve ments might be related to uneven ramp-up of coverage for specifi c method of reproductive health careantenatal care, in-facility delivery, skilled birth attendance, family planning services, EmOC, and post natal care-that are all known to decrease the risk of bad pregnancy outcomes. 40, 41 Indeed, increasing use of reproductive health services was one of the driving factors behind establishment of the Janani Suraksha Yojana conditional cash transfer programme in India. Janani Suraksha Yojana has been successful at increasing reproductive health-care services, but even despite its popularity this programme has not been as eff ective at reaching poor rural women, the sociodemographic group that is already at highest risk of adverse pregnancy outcomes. 42 In addition to the Janani Suraksha Yojana programme in India, other countries such as Nepal, Mexico, El Salvador, Honduras, Guatemala, Uruguay, and Brazil have also had success in encouraging use of reproductive care services, 43, 44 so this might be a viable option for countries seeking to increase women's use of reproductive health-care services. Fourth, the highest SDI geographies are likely also experiencing a confl uence of factors leading to higher-risk pregnancies and subsequently higher than expected MMR-namely, delay of fertility to older ages and a corresponding increase in the proportion of pregnant women with noncommunicable diseases (NCDs). Other direct maternal disorders are the dominant cause of maternal death in high SDI locations, driven by cardiomyopathy and obstetric embolism, both of which are of higher risk in older women and those with preexisting conditions such as hypertension, obesity, and diabetes. 45, 46 If the trend of increasing NCDs continues and, barring any breakthrough in preventing such complications, we could reasonably expect to see MMR increases begin to emerge in other regions besides those in the highest SDI.
Because of the importance of reproductive care coverage in overall reproductive health, and to help to guide specifi c coverage targets for achieving SDG 3.1 and 3.7, comparable metrics and monitoring on coverage of all of these reproductive health services should be integrated into regular progress reports at the global, regional, national, and subnational levels, including the development of comprehensive strategies to reach those targets. Our analysis found that an MMR of 70 is expected with an SDI level of 0·65, which corresponds to an average income of international $2648 per capita, a total fertility rate of 2·0, and completing 12 years of education, so even lower income countries might have a path to SDG 3.1 attainment. An MMR of 70 is also associated with about 91% coverage of one antenatal care visit, 78% of four antenatal care visits, 81% of in-facility delivery, and 87% of skilled birth attendance. Higher MMR locations have historically had much lower coverage of these services, particularly in-facility delivery and skilled birth attendance, and increasing access to them will require sustained focus.
Quality of care must also be a focus as coverage of family planning services, antenatal care, in-facility delivery, skilled birth attendance, EmOC, and postnatal care increase, because the existence of these programmes by themselves is not suffi cient to ensure that women are receiving the care they need during pregnancy and the post-partum period. 47 Care should be integrated and not be focused on single vertical interventions. 48 Family planning services should be longitudinal and include provision of comprehensive sex education, multiple methods of modern contraception, and access to safe abortion. 49 High-quality antenatal care should refl ect appropriate use of services, good communication between patient and provider, and reliable screening and treatment for infectious diseases (eg, sexually transmitted infections), chronic conditions (eg, blood disorders, obesity, substance abuse, renal dysfunction, rheumatic, or other heart disease) and pregnancy abnormalities (eg, anaemia, nutritional defi ciencies, blood pressure, glucose, urine protein, fetal growth anomalies). 50, 51 Infacility delivery and skilled birth attendance services must be adequately staff ed to meet demand and, because not all major complications of pregnancy are avoidable or easily predictable, women need to have ready access to well-functioning basic and comprehensive EmOC services. These services must be appropriately distributed to meet demand 52 and be staff ed by suffi cient numbers of trained midwives, nurses, and anaesthesia and obstetrical providers to meet demand, including on nights and weekends. Health professionals in EmOC facilities also need to have appropriate equipment including medications, access to blood transfusion materials, and intensive care services to help to prevent complications from leading to death. 53, 54 Post natal care should focus on detection and treatment of those conditions known to be more common in the post-partum and late maternal period, including cardiomyopathy, pulmonary embolism, and renal complications. 55, 56 In countries with generalised HIV epidemics, AIDS-related deaths have also been observed to commonly occur 42 days or more after pregnancy ends, and care eff orts for HIV-positive mothers should focus on ensuring uninterrupted antiretroviral treatment. 57, 58 Late maternal death statistics need to be improved. Maternal mortality surveillance studies such as confi dential enquiry have showed that late maternal death is non-trivial in even low-resource settings 34, 59 and can account for up to 40% of maternal deaths in highincome settings. 60 A contemporary linkage study in Mexico found that 18% of maternal deaths are missed when the defi nition is truncated at 42 days' post partum. 61 As immediate mortality continues to decrease as a result of improved antenatal, obstetric, and post-partum care, it is therefore increasingly likely that the proportion of late maternal deaths will continue to increase. Despite knowledge of its importance, only a few countries using ICD-10 reliably code late maternal deaths. This is especially egregious because many of the same countries who have completed multiple confi dential enquiries also have not recorded a single late maternal death in their offi cial statistics. Denmark, Ireland, Finland, and the UK all fall into this category. Australia, France, and South Africa likewise completed multiple confi dential enquiries and have recorded a total of eight maternal deaths combined in the entirety of their offi cial statistics. This is the exact inverse of the USA where no nationally comprehensive confi dential enquiries have been completed (although some states have established maternal mortality review boards). The USA has high MMR for a high-SDI country-and is one of the few where it is increasing-but following the lead of Mexico and much of Latin America, it is also one of the only countries that has proactively improved its civil registration system with addition of a pregnancy checkbox on the standard death certifi cate, 62 so it is possible that at least a portion of the increase is related to enhanced case ascertainment. 62 The USA should learn from the experiences of other countries and consider implementing regular, comprehensive confi dential enquiries into drivers of maternal mortality. Other countries and subnational locations should follow the lead of the countries of the Americas by adding pregnancy checkboxes to their offi cial death certifi cates and also ensuring that cooperation between their national statistics offi ce and confi dential enquiries committees maximises data quality. WHO also recently published a set of maternal mortality estimates for 1990 to 2015 63, 64 65 These included diff erences in dataset content, data processing methods, all-cause mortality, model specifi cation, quantifi cation of uncertainty, the use of CoDCorrect to ensure consistency between all specifi c causes of death, and the fact that MMEIG 2013 combined three separate estimation methods for diff erent categories of countries, whereas GBD uses one approach for all countries.
MMEIG has made some important modifi cations to their analysis since 2013-most notably implementation of a Bayesian approach that combines all countries into a single model to estimate maternal mortality cause fractions (the proportion of all deaths in the population that are due to maternal causes). These changes are especially apparent in estimates for a number of countries, including Bosnia and Herzegovina, Cyprus, Estonia, Finland, Georgia, Kiribati, Latvia, Malaysia, Mongolia, Romania, Russia, South Korea, and Sri Lanka. Figure 9 compares the country-specifi c trends from 1990 to 2015 between the two analyses. Whereas GBD 2015 identifi ed only ten countries as likely having achieved MDG 5, MMEIG 2015 found a total of 18 achieved the MDG 5 target. Because both groups use the same set of livebirths estimates from the UN Population Division, with the exception that GBD 2015 estimated maternal mortality for the entire age range from 10-54 years, diff erences in fertility are unlikely to be a major driver of diff erences between the two results. Drivers of diff erences can thus be best summarised as being due to diff erences in maternal cause fraction estimates or diff erences in all-cause mortality numbers as shown in the appendix (pp 499-518).
Global MMR estimates in 1990 were much higher in the MMEIG 2015 analysis, driven largely by higher estimates of maternal cause fraction in subSaharan Africa, south Asia, central Asia, central Latin America, and north Africa and the Middle East. 2015 MMEIG all-cause mortality estimates for 1990 were also higher in many of these same regions as well as in tropical and Andean Latin America, all of which led to higher MMR estimates than those produced by GBD 2015. Of note, GBD 2015 maternal cause fraction estimates were higher in most high-income regions, central Europe, and Oceania. By contrast, our decomposition of the drivers of diff erences in 2015 estimates show that diff erences in maternal cause fraction and all-cause mortality estimates narrowed in south Asia, central Asia, and much of sub-Saharan Africa, which has on aggregate led to broad agreement in global MMR fi gures for 2015. GBD 2015 estimates of maternal cause fraction estimates remain notably higher in high-income North America, western Europe, and Oceania, although it is likely that much of this is driven by MMEIG 2015 exclusion of late maternal mortality.
The total number of sources used by MMEIG 2015 was 203 and by GBD 2015 was 599 (appendix pp 677-83 shows all country-specifi c sources by type used in each analysis). For a number of populous countries-including China, Ethiopia, Indonesia, and India-diff erences in maternal cause fraction estimates are largely driven by dataset content. MMEIG 2015 did not include data from Medical Certifi cation of Cause of Death 66 or the Survey of Causes of Death 67 from India, several years of census and verbal autopsy data from Indonesia and Ethiopia, and maternal mortality surveillance data from China. MMEIG 2015 similarly did not include vital registration data from Iran and the Dominican Republic or sibling history from Jordan, all of which led to very diff erent estimates of levels and trends of maternal mortality in those countries. In total, 396 sources were excluded by MMEIG 2015. In many cases the MMEIG 2015 documentation does not describe reasons for not including these data. In future iterations of both the GBD and MMEIG estimation, the groups should both work more closely to ensure relevant data sources are included in both analyses.
Diff erences in processing methods of sibling history data are important, especially for countries in sub-Saharan Africa. The nine countries without maternal mortality data in the GBD 2015 analysis were Andorra, Angola, Equatorial Guinea, the Federated States of Micronesia, Marshall Islands, Samoa, Solomon Islands, Somalia, and Vanuatu. GBD 2015 used single-year sibling history survival data from each source, applied Gakidou-King weights to adjust for survivor bias, corrected for incidental HIV deaths using country-year-age-specifi c information about the population attributable fraction of HIV to maternal death, and used Bayesian noise-reduction algorithms to help to reduce stochastic variability in data. On aggregate, this approach maximises capture of underlying information about levels and trends of pregnancy-related mortality in health surveys. MMEIG 2015 combined all data from each survey and assigned them to the midpoint year of the recall period. They then uniformly applied a correction factor to reduce every datum by 10% or 15%, depending on the geography. The resulting MMEIG dataset is fairly sparse in some locations, and estimates are driven by regression coeffi cients. Examples can be seen in Democratic Republic of the Congo, Ethiopia, Ghana, and Saudi Arabia (see appendix pp 303-498). We would encourage MMEIG to consider using single-year sibling history data in their future analyses, because this diff erence in data processing might be driving divergence in trends from the early part of the MDG period, especially in sub-Saharan Africa.
Another important dataset diff erence is in the method used for processing and adjustment of vital registration data. GBD uses a standardised approach for all causes of death, empirically analysing every location's single-year vital registration quality to guide dynamic adjustments to raw data (appendix pp 519-652). In past studies, MMEIG applied a default correction factor of 1·5 to all vital registration data. That method was modifi ed in two ways in 2015. First, correction factors for vital registration were adjusted to match the deaths in published surveillance studies for those countries that had completed them. Second, MMEIG 2015 reclassifi ed selected recent years of vital registration data as special studies. These reclassifi ed years were not subjected to the 1·5 correction factor, but earlier years were. This reclassifi cation resulted in estimates showing faster declines in the MMR than are supported by raw data. These eight countries where the MMEIG results are aff ected by the selective vital registration reclassifi cation are Brazil, Costa Rica, Cuba, Ecuador, Guatemala, Kazakhstan, Mexico, and Uruguay. The criteria used for reclassifi cation of vital registration as special studies are not clearly documented, and it is unclear if these criteria have been objectively applied to all country-years of vital registration.
MMEIG implemented a Bayesian approach to estimate maternal mortality for the fi rst time in their 2015 estimates, which substantially improved their model fi t in countries with long time series of data. However, the base MMEIG model still relied on a simple linear mixed-eff ects model with only three covariates-gross domestic product, general fertility rate, and skilled birth attendance-and country random eff ects. By contrast, the GBD 2015 used four families of statistical models and used 15 diff erent covariates to develop ensemble models that were chosen based on a robust out-of-sample validity testing. MMEIG models were developed for the aggregate age range of 15-49 years, while the GBD 2015 estimates were generated separately for nine diff erent 5-year age bands ranging from 10-54 years. The latter approach has the noted advantage of being able to automatically adjust for compositional bias if the age structure of the sample population is diff erent from the general population. This approach also facilitates insight into potentially divergent age trends in maternal mortality within individual populations, matching them with corresponding shifts in age-specifi c fertility. Such an approach is crucial to singling out-for example-the contribution of adolescent fertility to overall maternal mortality levels and trends in maternal mortality. We therefore believe age-specifi c maternal mortality estimates, covering the entire reproductive age range, should be standard practice.
While recognising the potential caveats of adult mortality rates estimated using sibling survival, we made important improvements in GBD 2015 in accounting for selection bias and recall bias. We incorporated the uncertainty around adult mortality rate into our all-cause mortality estimation process for countries aff ected by HIV/AIDS in the sub-Saharan Africa regions. We did this by using single-year data for adult mortality rate from sibling survival modules-instead of pooled data for 5-year periods-and the crude death rate due to HIV/AIDS into the space-time Gaussian process regression that generates adult mortality rate estimates. This approach helped to reconcile between all-cause mortality estimates based on demographic sources and the HIV-specifi c mortality estimates using EPP-Spectrum, thus allowing us to better capture levels and trends of mortality in adult women, especially in western and central sub-Saharan Africa. By contrast, mortality estimates from World Population Prospects 2015 do not incorporate all available data, do not explicitly reconcile HIV-related and background mortality estimates, and for many countries are largely based on a tabular model life table system derived from that age pattern of mortality from countries in the 1950s and 1960s and a single entry parameter, the under-5 mortality rate. Such a system is likely to misrepresent the changing relation between mortality in child age groups and adult age groups 68 and, as we see from World Population Prospects 2015, all-cause mortality estimates in the 1990s, might overestimate mortality in western and central subSaharan Africa. 69 The GBD approach to quantifi cation of uncertainty assumes that uncertainty is uncorrelated in all locations. MMEIG has in the past assumed uncertainty is 50% correlated and 50% uncorrelated. This approach has led to very large uncertainty intervals in many countries and at the global level in past reports. MMEIG 2015 has implemented a more rigorous statistical approach to estimate uncertainty but has chosen the non-standard step of reporting only 80% UIs, despite the general global health practice of reporting 95% UIs. The rationale provided for this decision was that 95% UIs cannot be reliably interpreted, although why 80% intervals are more interpretable is unclear. In the interests of transparency and comparability to other analyses such as the GBD, we hope that in future estimates MMEIG will provide 95% UIs along with other narrower intervals.
This analysis, like many before it, has a number of limitations. First, despite continued increase in the size and breadth of our data sources, we still have no data for maternal mortality from several countries and territories. In several other locations, especially low-SDI regions, we continue to rely on data reporting aggregate pregnancy-related deaths from surveys and censuses. Unlike verbal autopsy and vital registration sources, survey and census data sources do not diff erentiate between maternal and non-maternal (incidental) deaths during pregnancy. The degree to which underreporting due to survival and recall bias off sets overreporting due to inclusion of incidental deaths is unclear and is further reason to advocate for improved data collection eff orts. Second, although we report results on the entire period from 1990 to 2015, because of large lag times in release of data we have not been able to include any data from 2015 and data from only 13 countries from 2014. Final 2015 results are thus based on recent historical data and model results. Third, our CODEm models have limited ability to capture non-stochastic rapid increases and decreases that might occur as a result of epidemics such as Ebola virus and H1N1 infl uenza, 70, 71 armed confl icts, 72 or other events. Fourth, this report has examined nine specifi c causal categories of maternal death, but this classifi cation system is certainly not exhaustive. We have not evaluated the contributions of some important chronic conditions known to increase risk to pregnant women such as obesity, diabetes, heart disease, haemoglobinopathies, such as sickle cell disease, chronic kidney disease, and chronic hypertension, or specifi c risk factors that might contribute to mortality. Our evaluation of ectopic pregnancy, abortion, and miscarriage together limits the ability to specifi cally quantify the burden of unsafe abortion. We likewise have not disaggregated the other direct obstetric complications category to quantify the relative importance of anaesthesia complications, cardio myopathy, and pulmonary embolism, all of which are known to be important contributors to maternal mortality in many settings. Continuing to improve on the specifi city of our analysis of the underlying cause of maternal death will be expected to improve the clinical use of GBD estimates. Fifth, while the GBD approach has the ability to provide excellent detail on geographic and temporal trends in maternal mortality, it has limited ability to explore subpopulations that are not geographically based, including indigenous populations or other high-risk groups who might have higher MMR due to cultural, religious, or other diff erences.
In conclusion, a shift from a relative target of percent reduction in MDGs to an absolute threshold target of an MMR of 70 in the SDGs has important ramifi cations. It will emphasise countries with high maternal mortality rates over those that have already achieved the goal. Such emphasis might be benefi cial in that it should help to focus additional international attention and resources on those countries who have the farthest distance to go. On the other hand, pre-emptive so-called achievement of SDG 3·1 has the potential to sap political and fi nancial investment in reproductive health in countries that still have major numbers of preventable maternal deaths, especially when continued progress is likely to depend largely on improvements in overall health systems performance. [73] [74] [75] [76] [77] One approach to mitigate this risk would be to promote SDG 3.1 not only as a threshold goal for nations on aggregate, but also as a target for all subpopulations within each. This approach will require all stakeholders to make disaggregated data and information about women's, children's, and adolescents' health publicly available. 5 Furthermore, as the global community pursues SDG 3.1, monitoring and reporting on all aspects of reproductive health care as outlined in SDG 3.7 will be important. 5 Achievement of this will require the international community to pay heed to the intricately related issues of immigration, armed confl icts, epidemics and pandemics, environment, economic instability, and gender equality, all of which can have substantial eff ects on the availability and quality of reproductive health services and women's willingness to seek them.
Global progress in reducing maternal mortality has been accelerating in the past 15 years, but there is still major work left to do. More than 250 000 women died during or following pregnancy in 2015, most of which were preventable deaths. Every woman that died left children, widowers, family, and their communities behind. The quantitative eff ect of MDG 5 is diffi cult to measure, but it is even harder to dispute the notion that it has united the international community in striving to decrease maternal mortality. With the ratifi cation of SDG 3.1 and SDG 3.7, relevant stakeholders need to make informed decisions about how to prioritise actions needed to bring about continued progress, and they can only do that with better data. As we continue on the path toward 2030, necessary and urgent steps will include rapid improvement in cause of death data collection systems and data dissemination coupled with more eff ective and widespread action and policies to promote education of girls and women, provide them with comprehensive family planning services, and ensure that each and every woman has access to the types of reproductive care they need to survive-and thrive.
